19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Prevalence of awareness, ever‐use and current use of nicotine vaping products (NVPs) among adult current smokers and ex‐smokers in 14 countries with differing regulations on sales and marketing of NVPs: cross‐sectional findings from the ITC Project

      research-article
      1 , , 1 , 1 , 1 , 2 , 1 , 1 , 1 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 5 , 10 , 6 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 1 , 19
      Addiction (Abingdon, England)
      John Wiley and Sons Inc.
      E‐cigarettes, global, income classification, nicotine vaping products (NVPs); smoking; international; regulations, policies, survey

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aims

          This paper presents updated prevalence estimates of awareness, ever‐use, and current use of nicotine vaping products (NVPs) from 14 International Tobacco Control Policy Evaluation Project (ITC Project) countries that have varying regulations governing NVP sales and marketing.

          Design, Setting, Participants and Measurements

          A cross‐sectional analysis of adult (≥ 18 years) current smokers and ex‐smokers from 14 countries participating in the ITC Project. Data from the most recent survey questionnaire for each country were included, which spanned the period 2013–17. Countries were categorized into four groups based on regulations governing NVP sales and marketing (allowable or not), and level of enforcement (strict or weak where NVPs are not permitted to be sold): (1) most restrictive policies (MRPs), not legal to be sold or marketed with strict enforcement: Australia, Brazil, Uruguay; (2) restrictive policies (RPs), not approved for sale or marketing with weak enforcement: Canada, Malaysia, Mexico, New Zealand; (3) less restrictive policies (LRPs), legal to be sold and marketed with regulations: England, the Netherlands, Republic of Korea, United States; and (4) no regulatory policies (NRPs), Bangladesh, China, Zambia. Countries were also grouped by World Bank Income Classifications. Country‐specific weighted logistic regression models estimated adjusted NVP prevalence estimates for: awareness, ever/current use, and frequency of use (daily versus non‐daily).

          Findings

          NVP awareness and use were lowest in NRP countries. Generally, ever‐ and current use of NVPs were lower in MRP countries (ever‐use = 7.1–48.9%; current use = 0.3–3.5%) relative to LRP countries (ever‐use = 38.9–66.6%; current use = 5.5–17.2%) and RP countries (ever‐use = 10.0–62.4%; current use = 1.4–15.5%). NVP use was highest among high‐income countries, followed by upper–middle‐income countries, and then by lower–middle‐income countries.

          Conclusions

          With a few exceptions, awareness and use of nicotine vaping products varied by the strength of national regulations governing nicotine vaping product sales/marketing, and by country income. In countries with no regulatory policies, use rates were very low, suggesting that there was little availability, marketing and/or interest in nicotine vaping products in these countries where smoking populations are predominantly poorer. The higher awareness and use of nicotine vaping products in high income countries with moderately (e.g. Canada, New Zealand) and less (e.g. England, United States) restrictive policies, is likely due to the greater availability and affordability of nicotine vaping products.

          Related collections

          Most cited references23

          • Record: found
          • Abstract: found
          • Article: not found

          Trends in Electronic Cigarette Use Among U.S. Adults: Use is Increasing in Both Smokers and Nonsmokers.

          We assessed trends in use of electronic cigarettes among U.S. adults, demographic predictors of use, and smoking status of current electronic cigarette users.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Global approaches to regulating electronic cigarettes

            Objectives Classify and describe the policy approaches used by countries to regulate e-cigarettes. Methods National policies regulating e-cigarettes were identified by (1) conducting web searches on Ministry of Health websites, and (2) broad web searches. The mechanisms used to regulate e-cigarettes were classified as new/amended laws, or existing laws. The policy domains identified include restrictions or prohibitions on product: sale, manufacturing, importation, distribution, use, product design including e-liquid ingredients, advertising/promotion/sponsorship, trademarks, and regulation requiring: taxation, health warning labels and child-safety standards. The classification of the policy was reviewed by a country expert. Results The search identified 68 countries that regulate e-cigarettes: 22 countries regulate e-cigarettes using existing regulations; 25 countries enacted new policies to regulate e-cigarettes; 7 countries made amendments to existing legislation; 14 countries use a combination of new/amended and existing regulation. Common policies include a minimum-age-of-purchase, indoor-use (vape-free public places) bans and marketing restrictions. Few countries are applying a tax to e-cigarettes. Conclusions A range of regulatory approaches are being applied to e-cigarettes globally; many countries regulate e-cigarettes using legislation not written for e-cigarettes.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Two-year trends and predictors of e-cigarette use in 27 European Union member states

              Objective This study assessed changes in levels of ever use, perceptions of harm from e-cigarettes and sociodemographic correlates of use among European Union (EU) adults during 2012–2014, as well as determinants of current use in 2014. Methods We analysed data from the 2012 (n=26 751) and 2014 (n=26 792) waves of the adult Special Eurobarometer for Tobacco survey. Point prevalence of current and ever use was calculated and logistic regression assessed correlates of current use and changes in ever use, and perception of harm. Correlates examined included age, gender, tobacco smoking, education, area of residence, difficulties in paying bills and reasons for trying an e-cigarette. Results The prevalence of ever use of e-cigarettes increased from 7.2% in 2012 to 11.6% in 2014 (adjusted OR (aOR)=1.91). EU-wide coefficient of variation in ever e-cigarette use was 42.1% in 2012 and 33.4% in 2014. The perception that e-cigarettes are harmful increased from 27.1% in 2012 to 51.6% in 2014 (aOR=2.99), but there were major differences in prevalence and trends between member states. Among those who reported that they had ever tried an e-cigarette in the 2014 survey, 15.3% defined themselves as current users. Those who tried an e-cigarette to quit smoking were more likely to be current users (aOR=2.82). Conclusions Ever use of e-cigarettes increased during 2012–2014. People who started using e-cigarettes to quit smoking tobacco were more likely to be current users, but the trends vary by country. These findings underscore the need for more research into factors influencing e-cigarette use and its potential benefits and harms.
                Bookmark

                Author and article information

                Contributors
                shannon.gravely@uwaterloo.ca
                Journal
                Addiction
                Addiction
                10.1111/(ISSN)1360-0443
                ADD
                Addiction (Abingdon, England)
                John Wiley and Sons Inc. (Hoboken )
                0965-2140
                1360-0443
                20 February 2019
                June 2019
                : 114
                : 6 ( doiID: 10.1111/add.v114.6 )
                : 1060-1073
                Affiliations
                [ 1 ] University of Waterloo Waterloo Ontario Canada
                [ 2 ] Medical University of South Carolina Charleston SC USA
                [ 3 ] Addictions Department, Institute of Psychiatry, Psychology and Neuroscience King's College London London UK
                [ 4 ] UK Centre for Tobacco and Alcohol Studies University of Nottingham Nottingham UK
                [ 5 ] Cancer Council Victoria Melbourne Australia
                [ 6 ] National Institute of Public Health Cuernavaca Morelos Mexico
                [ 7 ] Arnold School of Public Health Columbia SC USA
                [ 8 ] University of Otago Wellington New Zealand
                [ 9 ] University Sains Malaysia Penang Malaysia
                [ 10 ] Deakin University Geelong Victoria Australia
                [ 11 ] Maastricht University Maastricht the Netherlands
                [ 12 ] Centro de Investigación para la Epidemia del Tabaquismo Montevideo Uruguay
                [ 13 ] Universidad de la República Montevideo Uruguay
                [ 14 ] University of Zambia Lusaka Zambia
                [ 15 ] National Cancer Center Goyang‐si Gyeonggi‐do Republic of Korea
                [ 16 ] American Cancer Society Washington DC USA
                [ 17 ] Chinese Center for Disease Control and Prevention (China CDC) Beijing China
                [ 18 ] Brazil Cancer Foundation Rio de Janeiro Brazil
                [ 19 ] Ontario Institute for Cancer Research Toronto Canada
                Author notes
                [*] [* ] Correspondence to: Shannon Gravely, International Tobacco Control Policy Evaluation (ITC) Project, Department of Psychology, University of Waterloo, 200 University Avenue West, Waterloo, Ontario, Canada N2L 3G1. E‐mail: shannon.gravely@ 123456uwaterloo.ca
                Author information
                https://orcid.org/0000-0001-5224-9105
                https://orcid.org/0000-0003-2320-0999
                https://orcid.org/0000-0002-6223-4000
                https://orcid.org/0000-0003-0059-178X
                https://orcid.org/0000-0001-8167-6173
                https://orcid.org/0000-0003-4501-1398
                Article
                ADD14558 ADD-18-0573.R1
                10.1111/add.14558
                6510648
                30681215
                bf3806a7-1c02-4c31-ade1-9b62c412fdce
                © 2019 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 22 June 2018
                : 21 August 2018
                : 14 January 2019
                Page count
                Figures: 7, Tables: 1, Pages: 14, Words: 5646
                Funding
                Funded by: Brazil Fundação do Câncer
                Award ID: BR/LOA/1500048.001
                Funded by: Canadian Cancer Society
                Funded by: Canadian Institutes of Health Research
                Award ID: MOP 115016, FDN 148477
                Award ID: FDN 148477
                Award ID: MOP 115016
                Funded by: Chinese Centre for Disease Control and Prevention
                Funded by: Dutch Cancer Foundation
                Award ID: UM 2014‐7210
                Funded by: Health Research Council of New Zealand
                Award ID: GA215F 15/072
                Funded by: Korean Ministry of Health and Welfare
                Funded by: Mexican Consejo Nacional de Ciencia y Tecnología
                Award ID: Salud‐2007‐C01‐70032 and Salud‐2013‐01‐202671
                Funded by: National Cancer Institute of Brazil
                Funded by: Pan‐American Health Organization (PAHO)
                Funded by: US National Cancer Institute
                Award ID: P01CA138389, P01CA200512
                Award ID: R01 TW010652
                Award ID: P01CA200512
                Award ID: P01CA138389
                Funded by: Chinese Centre for Disease Control and Prevention, the Health Research Council of New Zealand
                Award ID: GA215F 15/072
                Funded by: National Cancer Institute of Brazil (INCA), Pan‐American Health Organization (PAHO), Brazil Fundação do Câncer
                Award ID: BR/LOA/1500048.001
                Funded by: Korean Ministry of Health and Welfare, the Dutch Cancer Foundation (KWF)
                Award ID: UM 2014‐7210
                Funded by: National Health and Medical Research Council of Australia
                Award ID: APP1106451
                Categories
                Research Report
                Research Reports
                Custom metadata
                2.0
                add14558
                June 2019
                Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.5 mode:remove_FC converted:26.06.2019

                Clinical Psychology & Psychiatry
                e‐cigarettes,global,income classification,nicotine vaping products (nvps); smoking; international; regulations,policies,survey

                Comments

                Comment on this article